Marijuana Abuse Clinical Trial
Official title:
Cue Reactivity Model for Assessing Pharmacologic Intervention in Treatment of Cannabis Use Disorders (Study 1)
The majority of past research on marijuana treatment has specifically targeted the alleviation of withdrawal symptoms. Minimal focus has been placed on how altering craving effects may play a role in treating marijuana addiction. The purpose of this study is to compare the effects of marijuana-related cues versus non marijuana-related cues in individuals both addicted and not addicted to marijuana. In turn, this may help establish a better understanding of the effects of marijuana cravings and may lead to improved treatments for marijuana dependence.
Marijuana is the most commonly used illegal drug in the United States; more than 2 million
Americans either abuse or are dependent on the drug. The development of a medication to
reduce marijuana use and prevent drug relapse by lessening withdrawal symptoms has been a
primary focus of research. However, there has been little emphasis on evaluating the
efficacy of a treatment that specifically reduces marijuana cravings. This study will
evaluate the subjective and physiological responses to marijuana-related cues versus non
marijuana-related cues in order to better understand the effects of marijuana cravings.
Participants will be divided into two groups. Group 1 will consist of 20 individuals
diagnosed with marijuana dependence; Group 2 will consist of individuals matched by age
range, gender and race to Group 1, and who are healthy volunteers and do not use marijuana
or who report limited marijuana exposure. Participants in Group 1 will spend one night at
the Psychiatric and Addiction Research Center at Detroit Receiving Hospital to control for
alcohol and drug use for 12 hours preceding the next day's 2-hour study session.
Participants in Group 2 are not required to spend the night, but are tested for drugs and
alcohol prior to the session. During the study session, both groups will be shown a nature
video and will be asked to handle and smell various items; these will act as the neutral,
non marijuana-related cues. Next, the participants will watch a video of individuals smoking
marijuana and will be asked to handle and smell marijuana-related items; these will act as
the marijuana-related cues. Heart rate and skin temperature will be monitored continuously
throughout the cue sessions with the use of electrodes and a skin thermometer. Prior to and
after the cue sessions, blood pressure will be measured and questionnaires will be
administered to assess drug cravings as well as related mood states. Prior to leaving the
laboratory, the participants' vital signs will be evaluated to ensure that any cue-related
physiological changes have returned to normal. Participants will have the option of talking
to a clinician experienced in dealing with drug cravings following the end of the study
session.
;
Observational Model: Case-Only, Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT01539525 -
Screening to Augment Referral to Treatment- Project START
|
Phase 2 | |
Completed |
NCT00158249 -
Effects of Citicoline on Brain Function and Behavior in Marijuana-Dependent Individuals
|
Phase 2 | |
Completed |
NCT00842985 -
Dronabinol Interactions in Humans
|
N/A | |
Completed |
NCT00484302 -
Specialized Addiction Treatment Versus Treatment as Usual for Young Patients With Cannabis Abuse and Psychosis
|
N/A | |
Completed |
NCT00227903 -
Therapeutic Substance Abuse Treatment in Pregnancy - 1
|
Phase 2 | |
Completed |
NCT00227864 -
A Brief Marijuana Intervention for Adolescent Women - 1
|
Phase 3 | |
Completed |
NCT00249509 -
Effectiveness of Nefazodone and Bupropion in Treating Marijuana Dependent Individuals
|
Phase 2 | |
Completed |
NCT03717272 -
Effect of AEF0117 on Subjective Effects of Cannabis in CUD Subjects
|
Phase 2 | |
Completed |
NCT00142961 -
Atomoxetine for Treating Marijuana-Abusing Adolescents Who Have Attention Deficit Hyperactivity Disorder
|
Phase 2 | |
Terminated |
NCT02102230 -
CBT-I for Cannabis Use
|
N/A | |
Completed |
NCT00580671 -
Treatment for Adolescent Marijuana Abuse
|
N/A | |
Completed |
NCT00360269 -
Atomoxetine Treatment for ADHD and Marijuana Dependence
|
Phase 2 | |
Completed |
NCT00227916 -
Motivational Interviews for Incarcerated Teens - 1
|
N/A | |
Completed |
NCT03154567 -
Effects of Stress and Drug-cue Exposure (SCM)
|
Phase 1 | |
Active, not recruiting |
NCT05322941 -
Effect of AEF0117 on Treatment-seeking Patients With Cannabis Use Disorder (CUD)
|
Phase 2 | |
Completed |
NCT02797990 -
Conflict Between Maternal Autonomy and Child Health in Substance-use
|
N/A | |
Completed |
NCT01762696 -
A Real-time, Contextual Intervention Using Mobile Technology to Reduce Marijuana Use in Youth
|
N/A | |
Completed |
NCT03154580 -
Marijuana Cue-Reactivity & Seeking Behavior in Regular Cannabis Users
|
Phase 1 | |
Completed |
NCT00218517 -
Effectiveness of Selegiline in Treating Marijuana Dependent Individuals - 1
|
Phase 2 | |
Completed |
NCT00142870 -
Effectiveness of Bupropion in Treating Marijuana Dependent Individuals
|
Phase 2 |